Detailed Quote
5i Report
Rating
B+
Review of WELL Health Technologies
AUG 30, 2022 - We believe the company’s acquisition model has worked well for the company and has positioned itself well in both Canada and the US. We would consider WELL to be our top pick for health care technology in Canada and maintain our rating of ‘B+’.
Download ReportCompany Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
- Dollarama Inc. (DOL)
- Gildan Activewear Inc. (GIL)
- Restaurant Brands International Inc. (QSR)
- Metro Inc. (MRU)
- WSP Global Inc. (WSP)
- Chartwell Retirement Residences (CSH.UN)
- TFI International Inc. (TFII)
- BRP Inc. Subordinate Voting Shares (DOO)
- Alimentation Couche-Tard Inc. (ATD)
- Premium Brands Holdings Corporation (PBH)
- Hammond Power Solutions Inc. Class A Subordinate Voting Shares (HPS.A)
- Aritzia Inc. Subordinate Voting Shares (ATZ)
- Vitalhub Corp. (VHI)
- WELL Health Technologies Corp. (WELL)
- Andlauer Healthcare Group Inc. Subordinate Voting Shares (AND)
- Boyd Group Services Inc. (BYD)
Q: Hello, Would you have 4 top picks in either of these sectors (industrials, consumer staples, consumer discretionary or health care). I am looking for large caps trading on the TSX with good long term potential. Thank you.
- NVIDIA Corporation (NVDA)
- Sun Life Financial Inc. (SLF)
- Intact Financial Corporation (IFC)
- goeasy Ltd. (GSY)
- Vitalhub Corp. (VHI)
- WELL Health Technologies Corp. (WELL)
- Super Micro Computer Inc. (SMCI)
- Vertiv Holdings LLC Class A (VRT)
- Propel Holdings Inc. (PRL)
Q: Hi,
I have been currently holding these for awhile and have done well on them, other than maybe WELL, which has been lagging a bit lately. Here are my allocations: WELL (1.7%), SLF (2%), GSY (3.5%) and NVDA (3.8%).
Recently in the last few months, I trimmed some NVDA and bought some VRT (1%) and SMCI (1%). For a growth investor, how would you rank these 3 stocks going forward? Would you continue to trim and buy these smaller cap higher growth names. With the run that they've had, I've been a little more cautious of a slowdown.
Also with these other names I'm holding, I'm contemplating trimming or completely switching to higher growth and better quality names with better runway for growth. What are your thoughts? Trim, add or switch? For example, does it make sense to trim a 3.0% position into two names that are only 1.5%? I'm against diworsification. Thank you!
1. WELL to VHI
2. SLF to IFC
3. GSY to PRL
I have been currently holding these for awhile and have done well on them, other than maybe WELL, which has been lagging a bit lately. Here are my allocations: WELL (1.7%), SLF (2%), GSY (3.5%) and NVDA (3.8%).
Recently in the last few months, I trimmed some NVDA and bought some VRT (1%) and SMCI (1%). For a growth investor, how would you rank these 3 stocks going forward? Would you continue to trim and buy these smaller cap higher growth names. With the run that they've had, I've been a little more cautious of a slowdown.
Also with these other names I'm holding, I'm contemplating trimming or completely switching to higher growth and better quality names with better runway for growth. What are your thoughts? Trim, add or switch? For example, does it make sense to trim a 3.0% position into two names that are only 1.5%? I'm against diworsification. Thank you!
1. WELL to VHI
2. SLF to IFC
3. GSY to PRL
Q: Hi 5i, trying to find a rose amongst thorns, and given the change in inclusion rates due to the budget, wouldn't this accelerate any deals in the pipeline? Not trying to be political.
#16Months2GO
#16Months2GO
Insiders
Share Information
News and Media